Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Partial upper sternotomy for aortic valve replacement provides similar mid-term outcomes as the full sternotomy

J. Hlavicka, D. Janda, P. Budera, P. Tousek, M. Maly, R. Fojt, H. Linkova, T. Holubec, P. Kacer

. 2022 ; 14 (4) : 857-865. [pub] -

Jazyk angličtina Země Čína

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22017459

Background: Minimally invasive aortic valve replacement via upper partial sternotomy (MiniAVR) provides very good short-term results and delivers certain advantages in the postoperative course. There is limited data regarding the mid-term mortality and morbidity following this minimally invasive surgery. Methods: We provide a retrospective analysis of the patients, undergoing MiniAVR versus full sternotomy (FS) for aortic valve replacement with biological prosthesis. As the primary combined end-point the combination of death, stroke, and rehospitalization within 3 years postoperatively was defined. Data have been collected from National Cardiac Surgery Registry and insurance companies. Results: Two hundred consecutive patients with aortic valve replacement (100 ministernotomy in MiniAVR group and 100 full sternotomy in FS group) with biological prosthesis were included in this study. Ministernotomy had longer cross-clamp and bypass times (median difference 6.5 min, P=0.005, and 8.5 min, P=0.002 respectively). Patients operated via upper partial sternotomy had a lower postoperative bleeding [300 mL (IQR, 290) vs. 365 mL (IQR, 207), P=0.031]. There was no difference in the 3-year mortality (14% vs. 11%, P=0.485). The mean number of readmission 3 years after surgery per capita was almost the same in both groups (1.65 vs. 1.60, P=0.836). Median time to the first readmission was longer in the MiniAVR group (difference 8.9 months). The incidence of combined end-point during 3 years postoperatively in both groups was not statistically different (P=0.148), as well as readmissions from cardio-vascular reasons (subhazard ratio 0.90, P=0.693). Conclusions: Upper partial sternotomy can be performed safely for aortic valve replacement, without increased risk of death, stroke or re-admission in 3 years postoperatively.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22017459
003      
CZ-PrNML
005      
20220720100233.0
007      
ta
008      
220718s2022 cc f 000 0|eng||
009      
AR
024    7_
$a 10.21037/jtd-21-1494 $2 doi
035    __
$a (PubMed)35572904
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a cc
100    1_
$a Hlavicka, Jan $u Department of Cardiovascular Surgery, Johann Wolfgang Goethe University Hospital, Frankfurt am Main, Germany $u Department of Cardiac Surgery, Charles University in Prague, Third Faculty of Medicine and Kralovske Vinohrady University Hospital, Prague, Czech Republic
245    10
$a Partial upper sternotomy for aortic valve replacement provides similar mid-term outcomes as the full sternotomy / $c J. Hlavicka, D. Janda, P. Budera, P. Tousek, M. Maly, R. Fojt, H. Linkova, T. Holubec, P. Kacer
520    9_
$a Background: Minimally invasive aortic valve replacement via upper partial sternotomy (MiniAVR) provides very good short-term results and delivers certain advantages in the postoperative course. There is limited data regarding the mid-term mortality and morbidity following this minimally invasive surgery. Methods: We provide a retrospective analysis of the patients, undergoing MiniAVR versus full sternotomy (FS) for aortic valve replacement with biological prosthesis. As the primary combined end-point the combination of death, stroke, and rehospitalization within 3 years postoperatively was defined. Data have been collected from National Cardiac Surgery Registry and insurance companies. Results: Two hundred consecutive patients with aortic valve replacement (100 ministernotomy in MiniAVR group and 100 full sternotomy in FS group) with biological prosthesis were included in this study. Ministernotomy had longer cross-clamp and bypass times (median difference 6.5 min, P=0.005, and 8.5 min, P=0.002 respectively). Patients operated via upper partial sternotomy had a lower postoperative bleeding [300 mL (IQR, 290) vs. 365 mL (IQR, 207), P=0.031]. There was no difference in the 3-year mortality (14% vs. 11%, P=0.485). The mean number of readmission 3 years after surgery per capita was almost the same in both groups (1.65 vs. 1.60, P=0.836). Median time to the first readmission was longer in the MiniAVR group (difference 8.9 months). The incidence of combined end-point during 3 years postoperatively in both groups was not statistically different (P=0.148), as well as readmissions from cardio-vascular reasons (subhazard ratio 0.90, P=0.693). Conclusions: Upper partial sternotomy can be performed safely for aortic valve replacement, without increased risk of death, stroke or re-admission in 3 years postoperatively.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Janda, David $u Department of Cardiac Surgery, Charles University in Prague, Third Faculty of Medicine and Kralovske Vinohrady University Hospital, Prague, Czech Republic
700    1_
$a Budera, Petr $u Department of Cardiac Surgery, Charles University in Prague, Third Faculty of Medicine and Kralovske Vinohrady University Hospital, Prague, Czech Republic
700    1_
$a Tousek, Petr $u Department of Cardiology, Charles University in Prague, Third Faculty of Medicine and Kralovske Vinohrady University Hospital, Prague, Czech Republic
700    1_
$a Maly, Marek $u National Institute of Public Health, Prague, Czech Republic
700    1_
$a Fojt, Richard $u Department of Cardiac Surgery, Charles University in Prague, Third Faculty of Medicine and Kralovske Vinohrady University Hospital, Prague, Czech Republic
700    1_
$a Linkova, Hana $u Department of Cardiology, Charles University in Prague, Third Faculty of Medicine and Kralovske Vinohrady University Hospital, Prague, Czech Republic
700    1_
$a Holubec, Tomas $u Department of Cardiovascular Surgery, Johann Wolfgang Goethe University Hospital, Frankfurt am Main, Germany
700    1_
$a Kacer, Petr $u Department of Cardiac Surgery, Charles University in Prague, Third Faculty of Medicine and Kralovske Vinohrady University Hospital, Prague, Czech Republic
773    0_
$w MED00194907 $t Journal of thoracic disease $x 2072-1439 $g Roč. 14, č. 4 (2022), s. 857-865
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35572904 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220718 $b ABA008
991    __
$a 20220720100228 $b ABA008
999    __
$a ind $b bmc $g 1816597 $s 1168701
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 14 $c 4 $d 857-865 $e - $i 2072-1439 $m Journal of thoracic disease $n J Thorac Dis $x MED00194907
LZP    __
$a Pubmed-20220718

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...